CPT® Code 82009

Official Description

Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); qualitative

Common Language Description

The CPT® Code 82009 refers to a qualitative test for ketone bodies, specifically measuring substances such as acetone, acetoacetic acid, and beta-hydroxybutyrate in the blood. This test is crucial for assessing the presence or absence of ketone bodies, which are byproducts of fat metabolism that can accumulate in the bloodstream under certain physiological conditions. The qualitative nature of this test means that it provides a visual assessment, often indicated by color changes, to determine the levels of ketone bodies present. This method is sometimes described as semi-quantitative due to its ability to show a range of results from low to high levels based on the intensity of the color change observed during the test. The presence of ketone bodies is particularly significant in clinical scenarios where carbohydrate utilization is impaired, such as in patients with diabetes mellitus, malnutrition, or conditions leading to inadequate caloric intake. Additionally, ketone bodies may be present in cases of vomiting or glycogen storage diseases. It is important to note that while this qualitative test provides valuable information regarding the presence of ketone bodies, a separate quantitative test (CPT® Code 82010) is available for measuring the exact levels of these substances in the blood, which is essential for managing conditions like diabetic and alcoholic ketoacidosis. The blood sample for this test is obtained through venipuncture, which is a separately reportable procedure, and the analysis is typically performed using gas chromatography to ensure accurate results.

1. Indications

Diabetes Mellitus The qualitative test for ketone bodies is indicated in patients with diabetes mellitus, particularly when there is a concern for ketoacidosis, a serious complication that can arise from insufficient insulin levels.

Malnutrition This test is also indicated in cases of malnutrition, where the body may begin to utilize fat stores for energy, leading to the production of ketone bodies.

Anorexia Patients experiencing anorexia may have inadequate caloric intake, prompting the need for this test to assess metabolic changes.

Vomiting The presence of ketone bodies can be indicative of metabolic disturbances in patients who are experiencing persistent vomiting.

Glycogen Storage Disease This test is relevant for individuals with glycogen storage diseases, where the body’s ability to store and utilize carbohydrates is impaired, potentially leading to ketone body production.

2. Procedure

Step 1: A blood sample is obtained from the patient through venipuncture, which involves inserting a needle into a vein to collect blood. This step is crucial as it provides the necessary specimen for testing.

Step 2: The collected blood sample is then processed to separate the serum, which is the liquid portion of the blood that contains the ketone bodies. This separation is essential for accurate testing.

Step 3: The serum is subjected to a qualitative analysis for ketone bodies. This is typically performed using a visual test method, where the serum is reacted with specific reagents that produce color changes based on the presence of ketone bodies.

Step 4: The results of the qualitative test are interpreted based on the color changes observed. The intensity of the color can indicate varying levels of ketone bodies, providing a semi-quantitative assessment of the patient's metabolic state.

3. Post-Procedure

After the procedure, the patient may be monitored for any immediate reactions to the venipuncture. The results of the qualitative test will be documented and communicated to the healthcare provider for further evaluation. Depending on the findings, additional testing or interventions may be warranted, especially if the presence of ketone bodies indicates a risk for conditions such as diabetic ketoacidosis. Patients may also receive guidance on dietary management or further assessments based on their clinical status and the results of the test.

Short Descr	KETONE BODYS QUAL
Medium Descr	KETONE BODYS QUALITATIVE
Long Descr	Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); qualitative
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
CLIA Waived (QW)	No
APC Status Indicator	Conditionally packaged laboratory tests
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	1
CCS Clinical Classification	233 - Laboratory - Chemistry and Hematology

26	Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
GW	Service not related to the hospice patient's terminal condition